DE2345695A1 - Verfahren zur herstellung neuer analoga bekannter prostaglandine - Google Patents

Verfahren zur herstellung neuer analoga bekannter prostaglandine

Info

Publication number
DE2345695A1
DE2345695A1 DE19732345695 DE2345695A DE2345695A1 DE 2345695 A1 DE2345695 A1 DE 2345695A1 DE 19732345695 DE19732345695 DE 19732345695 DE 2345695 A DE2345695 A DE 2345695A DE 2345695 A1 DE2345695 A1 DE 2345695A1
Authority
DE
Germany
Prior art keywords
radical
methyl
formula
carbon atoms
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732345695
Other languages
German (de)
English (en)
Inventor
Ernest Warren Yankee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DE2345695A1 publication Critical patent/DE2345695A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19732345695 1972-09-15 1973-09-11 Verfahren zur herstellung neuer analoga bekannter prostaglandine Pending DE2345695A1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28931772A 1972-09-15 1972-09-15
US05/374,405 US4100355A (en) 1972-09-15 1973-06-28 8β,12α-PGE2 -type compounds
US51869574A 1974-10-29 1974-10-29
US51854974A 1974-10-29 1974-10-29

Publications (1)

Publication Number Publication Date
DE2345695A1 true DE2345695A1 (de) 1974-03-28

Family

ID=27501499

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732345695 Pending DE2345695A1 (de) 1972-09-15 1973-09-11 Verfahren zur herstellung neuer analoga bekannter prostaglandine

Country Status (9)

Country Link
US (3) US4100355A (US06373033-20020416-M00035.png)
AU (1) AU469908B2 (US06373033-20020416-M00035.png)
BE (1) BE804873A (US06373033-20020416-M00035.png)
CA (1) CA1047491A (US06373033-20020416-M00035.png)
CH (2) CH605731A5 (US06373033-20020416-M00035.png)
DE (1) DE2345695A1 (US06373033-20020416-M00035.png)
FR (1) FR2199983B1 (US06373033-20020416-M00035.png)
GB (2) GB1449146A (US06373033-20020416-M00035.png)
NL (1) NL7312685A (US06373033-20020416-M00035.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089896A (en) * 1971-12-17 1978-05-16 Carlo Erba S.P.A. 8,12-Diisoprostanoic acid derivatives

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3291E (es) * 1975-04-23 1980-08-22 Upjohn Co Procedimiento para preparar analogos de prostaglandinas
US4955878A (en) * 1986-04-04 1990-09-11 Biotechnology, Inc. Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
US5190972A (en) * 1992-01-27 1993-03-02 The University Of Melbourne Method of combatting cyclosporine organ toxicity with prostaglandin analogs
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119855A1 (en) * 1970-12-29 1972-08-11 Roussel Uclaf Synthesis of prostaglandins - without loss of stereospecificity
CA963900A (en) * 1971-05-04 1975-03-04 Frank H. Lincoln (Jr.) Prostaglandin-type compounds
US3862984A (en) * 1971-07-02 1975-01-28 Upjohn Co 15-oxo,11{62 pgf{hd 2{b {301 and {331

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089896A (en) * 1971-12-17 1978-05-16 Carlo Erba S.P.A. 8,12-Diisoprostanoic acid derivatives

Also Published As

Publication number Publication date
NL7312685A (US06373033-20020416-M00035.png) 1974-03-19
US4100355A (en) 1978-07-11
US4084063A (en) 1978-04-11
BE804873A (fr) 1974-03-14
US4095036A (en) 1978-06-13
CA1047491A (en) 1979-01-30
FR2199983A1 (US06373033-20020416-M00035.png) 1974-04-19
GB1449147A (en) 1976-09-15
FR2199983B1 (US06373033-20020416-M00035.png) 1977-11-10
AU5943073A (en) 1975-03-13
GB1449146A (en) 1976-09-15
CH605731A5 (US06373033-20020416-M00035.png) 1978-10-13
AU469908B2 (en) 1976-02-26
CH593961A5 (US06373033-20020416-M00035.png) 1977-12-30

Similar Documents

Publication Publication Date Title
EP0030377B1 (de) 9-Chlor-prostaglandinderivate, Verfahren zur Herstellung und Verwendung als Arzneimittel
DE2322673A1 (de) Neue verbindungen vom prostaglandintyp und verfahren zu ihrer herstellung
EP0198829B1 (de) 9-halogen-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2423155A1 (de) 5-oxa-prostaglandine und verfahren zu deren herstellung
CH628028A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14.
EP0069696A2 (de) 9-Fluor-prostaglandinderivate, Verfahren zur Herstellung und Verwendung als Arzneimittel
DE2317019A1 (de) Neue 4,5-didehydro-prostaglandine
DE2734791A1 (de) Neue prostaglandin-i tief 2 -derivate und verfahren zu ihrer herstellung
DE2753244A1 (de) Neue prostacyclinderivate und verfahren zu ihrer herstellung
DE2641823A1 (de) Neue prostaglandin-analoga
DE2626888A1 (de) 11-desoxy-16-aryloxy-omega-tetranorprostaglandine
DE2423156A1 (de) 5-oxa-prostaglandine und verfahren zu deren herstellung
DE2638827A1 (de) Neue 11-deoxy-prostaglandine e, f tief alpha und f tief beta
DE2729960A1 (de) Neue acetylenprostaglandine und verfahren zu ihrer herstellung
DE2345695A1 (de) Verfahren zur herstellung neuer analoga bekannter prostaglandine
EP0510154B1 (de) 9-HALOGEN-11(Beta)-HYDROXY-PROSTAGLANDINDERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL
DE2510818C2 (de) Neue Prostaglandin-Analoge sowie ein Verfahren zu deren Herstellung, sowie Arzneimittel die diese enthalten
DE2610718A1 (de) Neue 16-phenoxy-prostaglandin-verbindungen
DE2719901A1 (de) Pge- und 11-deoxy-pge-verbindungen mit einer methylengruppe am c-9
DE2165184A1 (de) Neue Analoga bekannter Prostaglandine und Verfahren zu ihrer Herstellung
EP0015227A1 (de) Neue Prostacyclin-Derivate und Verfahren zu ihrer Herstellung
DE2606051A1 (de) 2,2-difluor-prostaglandin-e, -f tief alpha, -f tief beta, -a und -b-analoga und verfahren zu deren herstellung
DE2542686A1 (de) 2a,2b-dihomo-15-methyl- und -15- aethyl-pgf-und pge-verbindungen und verfahren zu deren herstellung
DE2320552A1 (de) 4,5-dihehydro-prostaglandine und verfahren zu ihrer herstellung
DE2716075A1 (de) Neue zwischenprodukte und verfahren zur herstellung von thromboxan-analoga

Legal Events

Date Code Title Description
OHN Withdrawal